Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$470,671,934
+$113,660,226 QoQ
Shares Held
1,853,258
+26.9% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#110
of 4,676 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pictet Asset Management Holding SA holds $3,393,842,702 across 13 Drug Manufacturers - General names. JNJ ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
754,985 | $905,551,734 | |
| 2 | AZN |
Astrazeneca PLC
|
2,937,510 | $557,010,646 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
1,853,258 | $470,671,934 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,511,962 | $317,361,279 | |
| 5 | AMGN |
Amgen Inc
|
872,311 | $315,881,259 | |
| 6 | ABBV |
AbbVie Inc.
|
909,328 | $228,823,297 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,451,505 | $186,518,392 | |
| 8 | BIIB |
Biogen Inc.
|
851,819 | $184,044,013 |
All Filings in JNJ
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $470,671,934 | 1,853,258 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $357,011,708 | 1,460,529 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $308,421,310 | 1,490,318 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $266,795,460 | 1,438,871 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $225,641,994 | 1,477,198 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $235,397,939 | 1,419,428 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $205,719,346 | 1,422,482 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $205,358,218 | 1,267,174 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $184,187,908 | 1,260,180 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $198,146,579 | 1,252,586 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $195,841,927 | 1,249,470 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $197,026,086 | 1,265,015 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||